Table 3 Multivariable competing risk regression analysis for predictors of LTFU among HIV-positive Adults at Pawi General Hospital, northwest Ethiopia, Jan 1, 2012–Dec 30, 2016
Variable | Survival status | cSHR [95% CI] | aSHR [95% CI] | ||
|---|---|---|---|---|---|
Lost (N = 136) | Death (N = 25) | Censored (N = 441) | |||
Age (years) | |||||
15–28 | 49 | 6 | 134 | 1 | 1 |
29–34 | 34 | 9 | 117 | 0.72 [0.47–1.11] | 0.76 (0.50–1.16) |
35–45 | 41 | 5 | 124 | 0.86 [0.57–1.3] | 0.85 (0.56–1.29) |
> 45 | 12 | 5 | 66 | 0.47 (0.25–0.89) | 0.44 (0.24–0.83) |
Sex | |||||
Female | 63 | 12 | 262 | 1 | 1 |
Male | 73 | 13 | 179 | 1.60 (1.14–2.23) | 1.40 (0.99–1.99) |
Nutritional status | |||||
Normal | 69 | 10 | 268 | 1 | 1 |
Malnourished | 67 | 15 | 173 | 1.38 (0.99–1.93) | 0.73 (0.52–1.02) |
WHO clinical stage | |||||
Stage (I/II) | 36 | 5 | 186 | 1 | 1 |
Stage III | 79 | 13 | 232 | 1.55 (1.05–2.29) | 1.34 (0.92–1.95) |
Stage IV | 21 | 7 | 23 | 2.77 (1.62–4.76) | 2.09 (1.19–3.67) |
Functional status | |||||
Asymptomatic | 85 | 6 | 353 | 1 | 1 |
Symptomatic | 51 | 19 | 88 | 1.63 (1.16–2.29) | 1.03 (0.72–1.45) |
Isoniazid | |||||
Not received | 115 | 20 | 125 | 1 | 1 |
Received | 21 | 5 | 316 | 0.11 (0.07–0.17) | 0.11 (0.07–0.18) |
CPT | |||||
Not received | 46 | 12 | 126 | 1 | 1 |
Received | 90 | 13 | 315 | 0.79 (0.56–1.12) | 0.84 (0.59–1.20) |
Opportunistic infection | |||||
No | 93 | 13 | 363 | 1 | 1 |
Yes | 43 | 12 | 77 | 1.58 (1.12–2.23) | 0.91 (0.63–1.30) |